Evidence map›Paper›PMID 32167602›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2020

Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90-Client Interactions.

Antonella Paladino, Mark R Woodford, Sarah J Backe, Rebecca A Sager, Priyanka Kancherla, Michael A Daneshvar, Victor Z Chen, Dimitra Bourboulia, Elham F Ahanin, Chrisostomos Prodromou and 11 more

Open access · greenAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Antonella PaladinoSCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.
Mark R WoodfordDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Sarah J BackeDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Rebecca A SagerDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Priyanka KancherlaDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Michael A DaneshvarDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Victor Z ChenDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Dimitra BourbouliaDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Elham F AhaninDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Chrisostomos ProdromouGenome Damage and Stability Centre, University of Sussex, Brighton, BN1 9RQ, UK.
Greta BergamaschiSCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.
Alessandro StradaSCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.
Marina CretichSCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.
Alessandro GoriSCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.
Marina VeronesiD3-PharmaChemistry, Istituto Italiano di Tecnologia (IIT), Genova, Italy.
Tiziano BandieraD3-PharmaChemistry, Istituto Italiano di Tecnologia (IIT), Genova, Italy.
Renzo VannaInstitute for Photonics and Nanotechnologies, IFN-CNR, c/o Dept. of Physics, Politecnico di Milano, Piazza L. Da Vinci 32, 20133, Milano, Italy.
Gennady BratslavskyDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Stefano A SerapianUniversity of Pavia, Department of Chemistry, Viale Taramelli 10, 27100, Pavia, Italy.
Mehdi MollapourDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Giorgio ColomboSCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.ORCID http://orcid.org/0000-0002-1318-668X
SUNY Upstate Medical University · USIstituto di Nanotecnologia · ITItalian Institute of Technology · ITUniversity of Pavia · ITPolitecnico di Milano · ITUniversity of Sussex · GB

Funding

Regulatory mechanisms of the Hsp90 chaperone machinery.R35GM139584 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2021 to 2025
$2.2M
Crosstalk between post-translational regulations of the FNIP co-chaperones and their impact on Hsp90 chaperone function and drug bindingR01GM124256 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2017 to 2020
$1.3M
Associazione Italiana per la Ricerca sul Cancro IG 20019NIGMS NIH HHS R01 GM124256NIGMS NIH HHS R35 GM139584NIH HHS R01GM124256
6 · The paper itself

Abstract

Protein folding quality control in cells requires the activity of a class of proteins known as molecular chaperones. Heat shock protein-90 (Hsp90), a multidomain ATP driven molecular machine, is a prime representative of this family of proteins. Interactions between Hsp90, its co-chaperones, and client proteins have been shown to be important in facilitating the correct folding and activation of clients. Hsp90 levels and functions are elevated in tumor cells. Here, we computationally predict the regions on the native structures of clients c-Abl, c-Src, Cdk4, B-Raf and Glucocorticoid Receptor, that have the highest probability of undergoing local unfolding, despite being ordered in their native structures. Such regions represent potential ideal interaction points with the Hsp90-system. We synthesize mimics spanning these regions and confirm their interaction with partners of the Hsp90 complex (Hsp90, Cdc37 and Aha1) by Nuclear Magnetic Resonance (NMR). Designed mimics selectively disrupt the association of their respective clients with the Hsp90 machinery, leaving unrelated clients unperturbed and causing apoptosis in cancer cells. Overall, selective targeting of Hsp90 protein-protein interactions is achieved without causing indiscriminate degradation of all clients, setting the stage for the development of therapeutics based on specific chaperone:client perturbation.

Indexed as

CarcinogensCell Cycle ProteinsChaperoninsHSP90 Heat-Shock ProteinsHumansMolecular ChaperonesProtein FoldingCarcinogensCell Cycle ProteinsChaperoninsHSP90 Heat-Shock ProteinsMolecular Chaperonesco-chaperonesheat shock protein Hsp90molecular recognitionprotein dynamicsprotein-protein interaction inhibitors

Identifiers

PMID32167602
PMCPMC7415569
OpenAlexW3010750273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.